Detalhe da pesquisa
1.
Mitochondrial haplogroups and cognitive progression in Parkinson's disease.
Brain
; 146(1): 42-49, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36343661
2.
Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.
Proc Natl Acad Sci U S A
; 117(52): 33608-33618, 2020 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33318181
3.
powerEQTL: an R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis.
Bioinformatics
; 37(22): 4269-4271, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34009297
4.
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study.
Mov Disord
; 37(5): 1016-1027, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106798
5.
Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping.
Cerebellum
; 2022 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190676
6.
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites.
Acta Neuropathol
; 141(5): 725-754, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694021
7.
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource.
Mov Disord
; 36(8): 1795-1804, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33960523
8.
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PDGBA.
Mov Disord
; 36(5): 1216-1228, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547828
9.
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Mov Disord
; 36(1): 106-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002231
10.
Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 91(7): 695-702, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303560
11.
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
Mov Disord
; 34(12): 1839-1850, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31505070
12.
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.
Hum Mol Genet
; 25(17): 3849-3862, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402877
13.
Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
Ann Neurol
; 80(3): 355-67, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351289
14.
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
Ann Neurol
; 80(5): 674-685, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717005
15.
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping.
Cerebellum
; 2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456723
16.
The NINDS Parkinson's disease biomarkers program.
Mov Disord
; 31(6): 915-23, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26442452
17.
α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
Cell Mol Neurobiol
; 36(3): 437-48, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993503
18.
Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease.
Brain
; 138(Pt 9): 2659-71, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26220939
19.
Metallothioneins as dynamic markers for brain disease in lysosomal disorders.
Ann Neurol
; 75(1): 127-37, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242821
20.
A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 91(6): 673-674, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241921